Form 4 for ACXP Acurx Pharmaceuticals, Inc.
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-23 · accession 0001104659-21-143551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-24 | 2021-11-23 | ACXP | Sailer Carl | Dir | P - Purchase | $4.84 | +5,161 | 73.1K | +8% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-23 | P | A | 5,161 | $4.84 | 73,078 | D | — | — | (F1) The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.73 to $4.86 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price. |